Syndax Pharmaceuticals Inc - Common Stock (SNDX)
CUSIP: 87164F105
Q4 2019 13F Holders as of 31 Dec 2019
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 86,727,396
- Total 13F shares
- 16,674,566
- Share change
- -471,003
- Total reported value
- $146,400,674
- Put/Call ratio
- 32%
- Price per share
- $8.78
- Number of holders
- 71
- Value change
- -$3,736,906
- Number of buys
- 31
- Number of sells
- 31
Quarterly Holders Quick Answers
What is CUSIP 87164F105?
CUSIP 87164F105 identifies SNDX - Syndax Pharmaceuticals Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 87164F105:
Top shareholders of SNDX - Syndax Pharmaceuticals Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.6%
|
3,097,523
|
$23,137,000 | — | 30 Sep 2019 | |
| MPM ASSET MANAGEMENT LLC |
13F
|
Company |
2.5%
|
2,168,691
|
$16,200,000 | — | 30 Sep 2019 | |
| BVF INC/IL |
13F
|
Company |
2%
|
1,764,784
|
$13,183,000 | — | 30 Sep 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2%
|
1,713,304
|
$12,799,000 | — | 30 Sep 2019 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.4%
|
1,250,000
|
$9,338,000 | — | 30 Sep 2019 | |
| 683 Capital Management, LLC |
13F
|
Company |
1.4%
|
1,171,648
|
$8,751,000 | — | 30 Sep 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
1,072,148
|
$8,009,000 | — | 30 Sep 2019 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.1%
|
956,940
|
$7,149,000 | — | 30 Sep 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.57%
|
497,000
|
$3,713,000 | — | 30 Sep 2019 | |
| STATE STREET CORP |
13F
|
Company |
0.48%
|
415,564
|
$3,104,000 | — | 30 Sep 2019 | |
| Boxer Capital, LLC |
13F
|
Company |
0.46%
|
400,000
|
$2,988,000 | — | 30 Sep 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.33%
|
286,238
|
$2,138,000 | — | 30 Sep 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.28%
|
243,713
|
$1,820,000 | — | 30 Sep 2019 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.28%
|
243,150
|
$1,817,000 | — | 30 Sep 2019 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.24%
|
212,000
|
$1,584,000 | — | 30 Sep 2019 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.24%
|
210,156
|
$1,570,000 | — | 30 Sep 2019 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.21%
|
180,000
|
$1,345,000 | — | 30 Sep 2019 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.17%
|
148,988
|
$1,113,000 | — | 30 Sep 2019 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.13%
|
108,576
|
$811,000 | — | 30 Sep 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.11%
|
91,378
|
$683,000 | — | 30 Sep 2019 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.09%
|
79,744
|
$596,000 | — | 30 Sep 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.08%
|
72,345
|
$540,000 | — | 30 Sep 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.06%
|
50,164
|
$375,000 | — | 30 Sep 2019 | |
| MCF Advisors LLC |
13F
|
Company |
0.04%
|
38,000
|
$284,000 | — | 30 Sep 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.04%
|
36,355
|
$271,000 | — | 30 Sep 2019 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
35,061
|
$262,000 | — | 30 Sep 2019 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
35,000
|
$261,000 | — | 30 Sep 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.04%
|
31,655
|
$236,000 | — | 30 Sep 2019 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
30,950
|
$231,000 | — | 30 Sep 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.04%
|
30,795
|
$230,000 | — | 30 Sep 2019 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.03%
|
30,100
|
$225,000 | — | 30 Sep 2019 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.03%
|
29,064
|
$217,000 | — | 30 Sep 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
27,712
|
$206,000 | — | 30 Sep 2019 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.03%
|
27,558
|
$206,000 | — | 30 Sep 2019 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
22,851
|
$171,000 | — | 30 Sep 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
22,737
|
$170,000 | — | 30 Sep 2019 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.03%
|
21,986
|
$164,000 | — | 30 Sep 2019 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
21,805
|
$163,000 | — | 30 Sep 2019 | |
| Bluefin Trading, LLC |
13F
|
Company |
0.02%
|
21,510
|
$161,000 | — | 30 Sep 2019 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.02%
|
20,500
|
$153,000 | — | 30 Sep 2019 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.02%
|
19,826
|
$148,000 | — | 30 Sep 2019 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.02%
|
17,735
|
$132,000 | — | 30 Sep 2019 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.02%
|
17,470
|
$131,000 | — | 30 Sep 2019 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.02%
|
17,000
|
$127,000 | — | 30 Sep 2019 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.02%
|
14,621
|
$113,000 | — | 30 Sep 2019 | |
| RAYMOND JAMES & ASSOCIATES |
13F
|
Company |
0.02%
|
15,000
|
$112,000 | — | 30 Sep 2019 | |
| BARCLAYS PLC |
13F
|
Company |
0.02%
|
14,884
|
$111,000 | — | 30 Sep 2019 | |
| Ibex Investors LLC |
13F
|
Company |
0.02%
|
13,754
|
$103,000 | — | 30 Sep 2019 | |
| Telemetry Investments, L.L.C. |
13F
|
Company |
0.01%
|
13,000
|
$97,000 | — | 30 Sep 2019 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
12,694
|
$95,000 | — | 30 Sep 2019 |
Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock (SNDX) as of Q4 2019
As of 31 Dec 2019,
Syndax Pharmaceuticals Inc - Common Stock (SNDX) was held by
71 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,674,566 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, MPM ASSET MANAGEMENT LLC, BVF INC/IL, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, 683 Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, and STATE STREET CORP.
This page lists
71
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2019 vs Q3 2019 Across Filers
Q3 2019 holders
72
Q4 2019 holders
71
Holder diff
-1
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 Value $ | Q4 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.